Picture of Kontafarma China Holdings logo

1312 — Kontafarma China Holdings News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Kontafarma China Notified That Shenzhen Stock Exchange Issued A Notice Of Criticism

Sept 19 (Reuters) - Kontafarma China Holdings Ltd
 1312.HK :
    * NOTIFIED THAT SHENZHEN STOCK EXCHANGE ISSUED A NOTICE OF
CRITICISM
    * NOTICE AGAINST SHENZHEN HUAKONG SEG CO AND INDIVIDUAL
    * MADE INQUIRIES WITH INDIVIDUAL
    * NOTED SZSE HAS NOT INDICATED THAT INCIDENT INVOLVED ANY
"DISHONESTY", "FRAUD" OR "INTEGRITY" ISSUE ON PART OF INDIVIDUAL
    * NOTED DECISION DOES NOT AFFECT QUALIFICATION OF INDIVIDUAL
AS
DIRECTOR
    * WILL NOT BE ANY MATERIAL ADVERSE IMPACT ON BUSINESS AND/OR
OPERATION OF ANY MEMBERS OF GROUP AS A RESULT OF DECISION
    * SZSE NOTIFIED HUAKONG SEG'S ESTIMATED NET PROFIT DISCLOSED
IN
2022 RESULTS FORECAST WAS DIFFERENT FROM DISCLOSED NET PROFIT

Further company coverage:  1312.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kontafarma China Holdings

See all news